Immunology Claims With Sources

 Quick Analysis Plan Copied

 Long Analysis Plan

What the Evidence Map Actually Demonstrates

The map contains three distinct mechanistic strands, but the central proposed link—STAT3 Ser727 phosphorylation driving NLRP3 mitochondrial translocation—is not directly demonstrated in any single experiment. Rather, it is an inferred convergence from two separately validated pathways:

Strand 1 — STAT3 Ser727 mitochondrial recruitment under ROS stress: Rotenone (0.5–2.5 µM) triggers dose- and time-dependent Ser727 phosphorylation of STAT3 in HeLa and HEK293 cells (n=3 replicates); pS727 STAT3 colocalizes with Tom20-positive mitochondria; NAC co-treatment suppresses both pS727 and mitochondrial STAT3 accumulation; and mitochondria-targeted WT STAT3 (but not the S727A mutant) reduces rotenone-induced ROS and rescues complex I activity (P<0.001) Rotenone-induced STAT3 Ser727 mitochondrial recruitment

Strand 2 — NEK7-licensed NLRP3 activation: A 3.8 Å cryo-EM structure (PDB 6NPY) reveals two NEK7–NLRP3 interfaces with Kd = 78.9 ± 38.5 nM; interface mutations (NEK7 Q129A/R131A/R136A; S260A/D261A/E265A) disrupt inflammasome activation in iBMDMs NEK7-NLRP3 cryo-EM structure and two-step activation model

Strand 3 — NLRP3 deubiquitination by BRCC3: BRCC3 removes K48 and K63 ubiquitin chains from NLRP3 (G5 inhibitor IC50 = 0.2 mM for blocking IL-1β secretion), identifying deubiquitination as a critical regulatory node BRCC3 deubiquitination regulates NLRP3

Critical Blind Spots and Missing Evidence

The decisive missing experiment is: does STAT3 Ser727 phosphorylation (or its absence via S727A) alter NLRP3 translocation to mitochondria, NEK7 binding, or ASC speck formation? None of the eight evidence units from the rotenone study measure any NLRP3 readout. Similarly, the NEK7 structural study does not measure STAT3. The map bridges these strands by inference, not observation.

Additional concerns: (1) No primary human macrophage data—all work uses immortalized lines (HeLa, HEK293, iBMDMs); (2) randomization and blinding are not reported in any study; (3) the mitochondrial fraction purity is not characterized in the STAT3 study; (4) the rotenone dose (0.5–2.5 µM) is pharmacological and may exceed physiological relevance; (5) NAC has broad redox effects beyond ROS scavenging, complicating causal attribution NLRP3 activation mechanisms review with debated ROS role

What Would Disprove or Strengthen the Map

The map would be weakened if: STAT3 S727A knock-in macrophages showed normal NLRP3 mitochondrial translocation and inflammasome activation; or if NLRP3 activation proceeded normally in STAT3-null cells. It would be strengthened by: co-immunoprecipitation of STAT3 with NLRP3 or NEK7 on mitochondria; NLRP3 translocation defects in STAT3 S727A-expressing macrophages; or proximity ligation/CLSM showing pS727 STAT3 physically adjacent to NLRP3 at the mitochondrial membrane during activation.

Confidence Assessment

Confidence that rotenone→ROS→pS727 STAT3→mitochondria is real in HeLa/HEK293: moderate-high (multiple independent readouts, pharmacological rescue, genetic mutants). Confidence that STAT3 Ser727 regulates NLRP3 mitochondrial translocation: low-uncertain (no direct evidence in this map; connection is speculative). Confidence in NEK7-NLRP3 structural model: high (cryo-EM + mutagenesis + biophysics convergence).